Biofourmis
Andrew Hedin is a seasoned professional with extensive experience in the healthcare venture capital and operations sectors. Currently serving as a Partner at Bessemer Venture Partners, Andrew has held roles including Operations at Remita Health and Healthcare VC at F-Prime Capital Partners. Previous experience includes an Associate position at Leerink Partners LLC, as well as a role as a Neuroscience Research Assistant at the University of Pennsylvania Department of Animal Biology, Neuroscience Laboratory. Andrew Hedin holds a Master of Business Administration (M.B.A.) in Health Care Management from The Wharton School and a Bachelor of Arts in Biological Basis of Behavior (Neuroscience) from the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
Biofourmis
6 followers
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.